Company: LGN
Filing Date: 2025-05-14
Form Type: DRS/A
Source: 0000950123-25-005247
Chunk: 175

Company: Legence Corp.
Filing Date: 2025-05-14
Form: DRS/A
Chunk 175
---
 serve as the chairman. As
required by the rules of the SEC and listing standards of the Nasdaq, the nominating and corporate governance committee will consist solely of independent directors, subject to the phase-in exceptions. Those
rules permit us to have a nominating and corporate governance committee that has one independent member at the date our Class A Common Stock is first listed on the Nasdaq, a majority of independent members within 90 days thereafter and all
independent members within one year thereafter.

This committee will identify, evaluate and recommend qualified nominees to serve on our
board of directors; develop and oversee our internal corporate governance processes and maintain a management succession plan. We have adopted a nominating and corporate governance committee charter to be effective upon the completion of this
offering defining the committee’s primary duties in a manner consistent with the rules of the SEC and the listing standards of the Nasdaq.

Compensation Committee Interlocks and Insider Participation

None of our executive officers serve on the board of directors or compensation committee of another public company that has an executive
officer that serves on our board of directors or compensation committee. No member of our board of directors is an executive officer of another public company in which one of our executive officers serves as a member of the board of directors or
compensation committee of that company.

Code of Business Conduct and Ethics

Prior to the completion of this offering, our board of directors will adopt a code of business conduct and ethics applicable to our employees,
directors and officers that will comply with applicable U.S. federal securities laws and the corporate governance rules of the Nasdaq. Any waiver of this code may be made only by our board of directors and will be promptly disclosed as required by
applicable U.S. federal securities laws and the corporate governance rules of the Nasdaq.

Corporate Governance Guidelines

Prior to the completion of this offering, our board of directors will adopt corporate governance guidelines in accordance with the corporate
governance rules of the Nasdaq.

118

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 COMPENSATION DISCUSSION AND ANALYSIS The purpose of this compensation discussion and analysis section is to provide information about the material elements of compensation that are paid, awarded to, or earned by, our “named executive officers,” who consist of our executive officers, including our principal executive officer and principal financial officer. For fiscal year 2024, our named executive officers were:

| • |     | Jeffrey Sprau, Chief Executive